Atricure Inc. buy JPMorgan Chase & Co.
Start price
16.12.25
/
50%
€34.60
Target price
16.12.26
€40.85
Performance (%)
-25.43%
Price
18.02.26
€27.40
Summary
This prediction is currently active. The price of Atricure Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -25.43%. This prediction currently runs until 16.12.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Atricure Inc. | - | - |
| iShares Core DAX® | -3.986% | -2.814% |
| iShares Nasdaq 100 | 0.345% | -0.748% |
| iShares Nikkei 225® | -3.853% | 4.229% |
| iShares S&P 500 | 0.298% | 0.379% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Atricure Inc. diskutieren
AtriCure (NASDAQ:ATRC) had its price target raised by analysts at JPMorgan Chase & Co. from $42.00 to $48.00. They now have an "overweight" rating on the stock.
Ratings data for ATRC provided by MarketBeat